title: Reply.
authors.affiliation: Departments of Internal Medicine and Pediatrics, Divisions of Allergy and Immunology, University of Tennessee College of Medicine, Memphis, Tenn. Electronic address: phillieberman@hotmail.com.
authors.forename: Phillip L
authors.initials: PL
authors.lastname: Lieberman
authors.affiliation: Global Product Development, Genentech, Inc, South San Francisco, Calif.
authors.forename: Dale T
authors.initials: DT
authors.lastname: Umetsu
authors.affiliation: Real World Data Science, Genentech, Inc, South San Francisco, Calif.
authors.forename: Gillis J
authors.initials: GJ
authors.lastname: Carrigan
authors.affiliation: Departments of Internal Medicine and Pediatrics, Divisions of Allergy and Immunology, University of Tennessee College of Medicine, Memphis, Tenn.
authors.forename: Abdelkader
authors.initials: A
authors.lastname: Rahmaoui
mesh_terms: D000707:Anaphylaxis; D006801:Humans; D000069444:Omalizumab
chemical_list: D000069444:Omalizumab